Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
62 Cards in this Set
- Front
- Back
4 patters of drug distribution
|
1-largely in vascular system-bound to plasma proteins
2-uniformly in water 3-Conc. in 1 or more sites(may not be site of action) 4- 1,2,3-MOST COMMON |
|
What cell makes BBB
|
endothelial cells
|
|
Loratadine vs Diphenhydramine
|
Loratadine doesnt cross BBB-nondrowsey
Diphen-Does-Drowesy |
|
Memb transporter acts as eflux carriers
|
P-glycoprotein
Organic Anion Transporter Polypepti (OATP) |
|
what Increases local permeability
|
Menigeal inflamm.
Encephalic inflamm. |
|
Placental Drug transfer depends upon?
|
Lipid Solubility
Degree of plasma binding Degree of Ionization |
|
What is Fetal pH
What does it cause |
7.0-More acidic than mothers
-Ion trapping |
|
Drug transform may render a drug ______, ________, or ____________
|
Benefical, harmful, or ineffective
|
|
Xenobiotics
|
Foreign subst that enters body
|
|
Drug metabolism
|
biochem rxns alter drug to be excreted or recycled
|
|
4 ways drugs are altered into more polar
|
1-Active Drug--->Inactive drug
2. AD--->Excretable drug 3. Inactive prodrug ---->Active drug 4. Unexcretable drug---> excretable |
|
Major site of Biotransform.
other significant sites |
Liver
Kidney, GI tract, skin, and lungs |
|
First Pass effect (Phenomenon)
|
Orally admin drug is immedi. inactivated
bypass by IV |
|
Phase I rxns
|
Hydrolytic
Oxidative Reductive |
|
Phase II rxns
|
adding Glucoronic acid, sulfate conjugates
|
|
MFO
|
family of Hemes, monooxygenases
adds one O from O2 to group |
|
P450 gets its name from?
|
P=pigment
450=450 nm in reduced form |
|
What is P450 associated with
|
NADPH-CYP450-Reductase
|
|
Where are CYP's in the cell
|
Smooth E.R.
|
|
Responsable for metabo. of 50% of drugs
|
CYP 3A4
|
|
1A2-what does it metab also?
|
Activity increased in smokers
-imipramine, warfarin, cipro |
|
2C9
|
Absent in !% of whites
|
|
2C19
what does it metab also? |
Absent in 15-20% asians
2-5% whites -Diazepam to Nordiazepam |
|
2D6
what does it metab also? |
Absent in 7% of whites
-Metab. Codeine to morphine |
|
2E1
|
Increas. by alcohol
|
|
Phase II occurs where?
what functional groups? |
cytosol
-Glucoronic acid -Acetate -Sulfate -Gluthathione -Amino Acids |
|
Inducers of P450?
|
2B1-phenobarb
3A-isoniazid 2E1-ethanol 1A1-pollutants |
|
Inhib of P450?
|
Cimetidine
Ketoconazole Secobarbital (causes toxic levels) |
|
Grapefruit juice inhibits?
chemical name? |
3A4
Narangenin |
|
Where is 3A4 found?
which one is inhib by G.F.J |
Liver and Intest. wall
-Intest. wall |
|
Inhibitors of 3A4
|
Ketoconazole, diltiazem, erythromycin, and narangenin(G.F.)
|
|
Inducers of 3A4
|
Carbamazepine
rifampicin |
|
Golmerular filt. filters?
|
molecules of low mol weight <60,000
most drugs unless bound to proteins |
|
Normal GFR?
|
110 to 130mL/min (180 L/DAY)
|
|
Prox reabsorbs
Requires? |
Water
energy and carrier |
|
Distal tubule
|
passive excretion
reabs. lipid soluble drugs |
|
Excretion pathway that is quantitatively unimportant
|
sweat
saliva tears |
|
First Order Kinetics
|
Most drugs follow
rate is prop to amt of drug in body half life is constant |
|
Zero Order
|
Rate is constant and fixed-indep of dosage entering ex ethanol
Half life not constant |
|
Vd
|
Volum of Distrib
Amt of drug in body to concen. of drug in plasma or blood high Vd= high lipid solub low Vd= lipid insolub |
|
Formula for Vd
|
Vd= dose of drug/ [drug] in plasma
|
|
Compartments in L
|
ICF-25-28
ECF-13-16 Plasma-3-4 |
|
CL equation
|
CL= Rate of Elim/ C plasma
|
|
system Cl
|
Cl sys= Cl renal + Cl hepatic +Cl lungs
|
|
Half life formula
|
T 1/2= .7(Vd)/ CL
|
|
Significance of Half Life
|
-indic first order eliminat mech.
-design dosage regimens -prolonged half life=disease or alt of mech. |
|
What always gives 100% bioavail.
|
IV
-used to compare against oral route |
|
Bioavail effected by?
|
Route of admin
extent of absorp. First pass effect |
|
criteria to be bioequivalence
|
-same active ingred.
-identical in strength and conc. -same rates and extent of bioavail. |
|
Dosing rate formula
|
DR=CL x Desired plasma C
|
|
Steady rate occurs when?
time relationship to dosage |
after 4 to 5 half lives
time is independent of dosage |
|
Loading Dose
|
LD=Vd x desired plasma C
|
|
ADME
|
Absorbed
Distributed Metab. Eliminated |
|
Pharmokinetics
|
dose-circ-distrib-metab or excret
|
|
Pharmacodynamics
|
Therapuetic action
-toxicity -Efficacy |
|
Absorption
|
Pass of drug thru cells into gen circul.
|
|
Distribution
|
Blood to ECF of cells
|
|
Metab
|
drugs into hepatic tissues
|
|
What determines kinetic prop?
|
Polarity
|
|
Absorption rate and effic depend upon?
|
route of admin.
|
|
what route of admin is erratic and incomplete
|
rectal 50% bypasses liver
|
|
Pharm Equivalents
|
Same active ingred., strength or conc, dosage form and route of admin
|